MLAB Quote, Financials, Valuation and Earnings

Focus Universal, Inc. has a net margin of 4.08% compared to Mesa Laboratories, Inc.'s net margin of -4064.11%. Mesa Laboratories, Inc.'s return on equity of -0.95% beat Focus Universal, Inc.'s return on equity of -254.53%.

Mesa Laboratories, Inc. has a consensus price target of $99.00, signalling upside risk potential of 22.72%. On the other hand Focus Universal, Inc. has an analysts' consensus of -- which suggests that it could fall by --. Given that Mesa Laboratories, Inc. has higher upside potential than Focus Universal, Inc., analysts believe Mesa Laboratories, Inc. is more attractive than Focus Universal, Inc..

Mesa Laboratories, Inc. has a beta of 0.901, which suggesting that the stock is 9.911% less volatile than S&P 500. In comparison Focus Universal, Inc. has a beta of 0.283, suggesting its less volatile than the S&P 500 by 71.657%.

Mesa Laboratories, Inc. has a quarterly dividend of $0.16 per share corresponding to a yield of 0.79%. Focus Universal, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Mesa Laboratories, Inc. pays 175.68% of its earnings as a dividend. Focus Universal, Inc. pays out -- of its earnings as a dividend.

Mesa Laboratories, Inc. quarterly revenues are $60.7M, which are larger than Focus Universal, Inc. quarterly revenues of $28.7K. Mesa Laboratories, Inc.'s net income of $2.5M is higher than Focus Universal, Inc.'s net income of -$1.2M. Notably, Mesa Laboratories, Inc.'s price-to-earnings ratio is -- while Focus Universal, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Mesa Laboratories, Inc. is 1.81x versus 26.63x for Focus Universal, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Keysight Technologies, Inc. has a net margin of 4.08% compared to Mesa Laboratories, Inc.'s net margin of 17.76%. Mesa Laboratories, Inc.'s return on equity of -0.95% beat Keysight Technologies, Inc.'s return on equity of 15.9%.

Mesa Laboratories, Inc. has a consensus price target of $99.00, signalling upside risk potential of 22.72%. On the other hand Keysight Technologies, Inc. has an analysts' consensus of $219.77 which suggests that it could grow by 7.03%. Given that Mesa Laboratories, Inc. has higher upside potential than Keysight Technologies, Inc., analysts believe Mesa Laboratories, Inc. is more attractive than Keysight Technologies, Inc..

Mesa Laboratories, Inc. has a beta of 0.901, which suggesting that the stock is 9.911% less volatile than S&P 500. In comparison Keysight Technologies, Inc. has a beta of 1.194, suggesting its more volatile than the S&P 500 by 19.432%.

Mesa Laboratories, Inc. has a quarterly dividend of $0.16 per share corresponding to a yield of 0.79%. Keysight Technologies, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Mesa Laboratories, Inc. pays 175.68% of its earnings as a dividend. Keysight Technologies, Inc. pays out -- of its earnings as a dividend.

Mesa Laboratories, Inc. quarterly revenues are $60.7M, which are smaller than Keysight Technologies, Inc. quarterly revenues of $1.4B. Mesa Laboratories, Inc.'s net income of $2.5M is lower than Keysight Technologies, Inc.'s net income of $252M. Notably, Mesa Laboratories, Inc.'s price-to-earnings ratio is -- while Keysight Technologies, Inc.'s PE ratio is 42.04x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Mesa Laboratories, Inc. is 1.81x versus 6.62x for Keysight Technologies, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Qorvo, Inc. has a net margin of 4.08% compared to Mesa Laboratories, Inc.'s net margin of 11.3%. Mesa Laboratories, Inc.'s return on equity of -0.95% beat Qorvo, Inc.'s return on equity of 6.36%.

Mesa Laboratories, Inc. has a consensus price target of $99.00, signalling upside risk potential of 22.72%. On the other hand Qorvo, Inc. has an analysts' consensus of $101.78 which suggests that it could grow by 18.15%. Given that Mesa Laboratories, Inc. has higher upside potential than Qorvo, Inc., analysts believe Mesa Laboratories, Inc. is more attractive than Qorvo, Inc..

Mesa Laboratories, Inc. has a beta of 0.901, which suggesting that the stock is 9.911% less volatile than S&P 500. In comparison Qorvo, Inc. has a beta of 1.366, suggesting its more volatile than the S&P 500 by 36.562%.

Mesa Laboratories, Inc. has a quarterly dividend of $0.16 per share corresponding to a yield of 0.79%. Qorvo, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Mesa Laboratories, Inc. pays 175.68% of its earnings as a dividend. Qorvo, Inc. pays out -- of its earnings as a dividend.

Mesa Laboratories, Inc. quarterly revenues are $60.7M, which are smaller than Qorvo, Inc. quarterly revenues of $1.1B. Mesa Laboratories, Inc.'s net income of $2.5M is lower than Qorvo, Inc.'s net income of $119.6M. Notably, Mesa Laboratories, Inc.'s price-to-earnings ratio is -- while Qorvo, Inc.'s PE ratio is 37.20x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Mesa Laboratories, Inc. is 1.81x versus 2.21x for Qorvo, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Sono-Tek Corp. has a net margin of 4.08% compared to Mesa Laboratories, Inc.'s net margin of 8.21%. Mesa Laboratories, Inc.'s return on equity of -0.95% beat Sono-Tek Corp.'s return on equity of 8.47%.

Mesa Laboratories, Inc. has a consensus price target of $99.00, signalling upside risk potential of 22.72%. On the other hand Sono-Tek Corp. has an analysts' consensus of $7.75 which suggests that it could grow by 90.42%. Given that Sono-Tek Corp. has higher upside potential than Mesa Laboratories, Inc., analysts believe Sono-Tek Corp. is more attractive than Mesa Laboratories, Inc..

Mesa Laboratories, Inc. has a beta of 0.901, which suggesting that the stock is 9.911% less volatile than S&P 500. In comparison Sono-Tek Corp. has a beta of -0.274, suggesting its less volatile than the S&P 500 by 127.432%.

Mesa Laboratories, Inc. has a quarterly dividend of $0.16 per share corresponding to a yield of 0.79%. Sono-Tek Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Mesa Laboratories, Inc. pays 175.68% of its earnings as a dividend. Sono-Tek Corp. pays out -- of its earnings as a dividend.

Mesa Laboratories, Inc. quarterly revenues are $60.7M, which are larger than Sono-Tek Corp. quarterly revenues of $5.2M. Mesa Laboratories, Inc.'s net income of $2.5M is higher than Sono-Tek Corp.'s net income of $423.7K. Notably, Mesa Laboratories, Inc.'s price-to-earnings ratio is -- while Sono-Tek Corp.'s PE ratio is 42.44x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Mesa Laboratories, Inc. is 1.81x versus 3.11x for Sono-Tek Corp.. Usually stocks with elevated PS ratios are considered overvalued.